Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study - Takeaways - MDSpire

Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study

  • By

  • Mohamed Abdalla Salman

  • Ahmed Saad

  • Ahmed Fahmy Omar

  • Mohannad Aly Fayed

  • Ahmed Saeed Hasan Saqr

  • Ahmed Abdalla

  • July 9, 2025

  • 0 min

Share

  • 1

    Obesity affects one-third of adults globally, leading to increased medical complications like dyslipidemia and type 2 diabetes.

  • 2

    Metabolic and bariatric surgery, particularly sleeve gastrectomy, is the most effective intervention for sustained weight loss.

  • 3

    Roux-en-Y gastric bypass is commonly performed for patients with suboptimal outcomes from sleeve gastrectomy.

  • 4

    This study compares long versus short biliopancreatic limb lengths in RYGB for weight loss and metabolic outcomes post-sleeve gastrectomy.

  • 5

    The randomized controlled trial included 110 patients, ultimately analyzing 98 for weight loss and metabolic profile at one-year follow-up.

Original Source(s)

Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study

  • by Mohamed Abdalla Salman, Ahmed Saad, Ahmed Fahmy Omar, Mohannad Aly Fayed, Ahmed Saeed Hasan Saqr, Ahmed Abdalla

  • July 9, 2025

Related Content

Retraction Note: Intrathoracic Migration of Gastric Sleeve Affects Weight Loss as well as GERD–an Analysis of Remnant Gastric Morphology for 100 Patients at One Year After Laparoscopic Sleeve Gastrectomy

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.